BIN1 and Arrhythmia: Utilizing an enzyme-linked immunosorbent assay (ELISA), Hong et al. found that a marked decrease (<30) in plasma BIN1 levels in patients with arrhythmogenic right ventricular cardiomyopathy can predict arrhythmia incidence with 82% and 79% sensitivity and accuracy, respectively [205].